@article{10542, keywords = {Administration, Inhalation, Adrenal Cortex Hormones/therapeutic use, Adrenergic beta-2 Receptor Agonists/therapeutic use, Bronchodilator Agents, Budesonide/adverse effects, Fluticasone/therapeutic use, Humans, Middle Aged, *Pneumonia/epidemiology/etiology, *Pulmonary Disease, Chronic Obstructive, COPD exacerbations, New-user cohort design, pneumonia, inhaled corticosteroids, long-acting bronchodilators, observational research, real-world evidence}, author = {S. Suissa and S. Dell'Aniello and P. Ernst}, title = {Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety}, year = {2022}, journal = {Copd}, volume = {19}, edition = {2022/04/07}, number = {1}, pages = {109-117}, isbn = {1541-2563}, doi = {10.1080/15412555.2022.2035705}, note = {1541-2563 Suissa, Samy Orcid: 0000-0002-1281-5296 Dell'Aniello, Sophie Ernst, Pierre Orcid: 0000-0001-9983-3608 Journal Article Observational Study England COPD. 2022;19(1):109-117. doi: 10.1080/15412555.2022.2035705.}, language = {eng}, }